OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
Elisa Bertoli, Elisa De Carlo, Debora Basile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10803-10803
Open Access | Times Cited: 14
Elisa Bertoli, Elisa De Carlo, Debora Basile, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10803-10803
Open Access | Times Cited: 14
Showing 14 citing articles:
Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types
Haiyang Hu, Huangqin Song, Bin Han, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 8
Haiyang Hu, Huangqin Song, Bin Han, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 8
Lung Cancer Research and Treatment: Global Perspectives and Strategic Calls to Action
May-Lucie Meyer, S. Peters, Tony Mok, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 6
May-Lucie Meyer, S. Peters, Tony Mok, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 6
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer
Chiara Reina, Berina Šabanović, Chiara Lazzari, et al.
Translational research (2024) Vol. 272, pp. 41-53
Closed Access | Times Cited: 4
Chiara Reina, Berina Šabanović, Chiara Lazzari, et al.
Translational research (2024) Vol. 272, pp. 41-53
Closed Access | Times Cited: 4
Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis
Francisco Cézar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Eric Pasqualotto, et al.
Clinical & Translational Oncology (2025)
Closed Access
Francisco Cézar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Eric Pasqualotto, et al.
Clinical & Translational Oncology (2025)
Closed Access
Personalized Approaches to Lung Cancer Treatment: A Review of Targeted Therapies, Pharmacogenomics, and Combination Strategies
M. Tabrizi Namini, G. Bhagya, Manjari Sharma
Aspects of Molecular Medicine (2025), pp. 100073-100073
Open Access
M. Tabrizi Namini, G. Bhagya, Manjari Sharma
Aspects of Molecular Medicine (2025), pp. 100073-100073
Open Access
Functional tumor-derived exosomes in NSCLC progression and clinical implications
Yuxin Gao, Jun Xie, Zhenya Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yuxin Gao, Jun Xie, Zhenya Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
liquid biopsy holds a promising approach for the early detection of cancer: Current information and future perspectives
Abdullah M. Shbeer, Ibrahim Ahmed Robadi
Pathology - Research and Practice (2024) Vol. 254, pp. 155082-155082
Closed Access | Times Cited: 3
Abdullah M. Shbeer, Ibrahim Ahmed Robadi
Pathology - Research and Practice (2024) Vol. 254, pp. 155082-155082
Closed Access | Times Cited: 3
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Volga Saini, Ezgi Öner, Mark P. Ward, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Volga Saini, Ezgi Öner, Mark P. Ward, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Liquid biopsy for monitoring minimal residual disease in localized and locally-advanced non-small cell lung cancer after radical-intent treatment
Héctor Aguilar, Belén López-Roldán, A. Vilalta, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100145-100145
Open Access | Times Cited: 2
Héctor Aguilar, Belén López-Roldán, A. Vilalta, et al.
The Journal of Liquid Biopsy (2024) Vol. 4, pp. 100145-100145
Open Access | Times Cited: 2
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database
Umberto Malapelle, Francesco Passiglia, Francesco Pepe, et al.
Lung Cancer (2024) Vol. 191, pp. 107787-107787
Open Access | Times Cited: 2
Umberto Malapelle, Francesco Passiglia, Francesco Pepe, et al.
Lung Cancer (2024) Vol. 191, pp. 107787-107787
Open Access | Times Cited: 2
A personalized approach to the management of rare genetic aberrations in oncology: A letter citing the EGFR exon 18 mutation molecular tumor board report
Sanidhya Pai, Ryan Varghese
Cancer Research Statistics and Treatment (2024) Vol. 7, Iss. 1, pp. 140-141
Open Access | Times Cited: 1
Sanidhya Pai, Ryan Varghese
Cancer Research Statistics and Treatment (2024) Vol. 7, Iss. 1, pp. 140-141
Open Access | Times Cited: 1
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Volga Saini, Ezgi Öner, Mark P. Ward, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 1
Volga Saini, Ezgi Öner, Mark P. Ward, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 1
Development of a nine-variant reference material panel to standardize cell-free DNA detection
Chunyan Niu, Jiejie Zhang, Yan Fang, et al.
Analytical and Bioanalytical Chemistry (2024) Vol. 416, Iss. 18, pp. 4123-4130
Closed Access
Chunyan Niu, Jiejie Zhang, Yan Fang, et al.
Analytical and Bioanalytical Chemistry (2024) Vol. 416, Iss. 18, pp. 4123-4130
Closed Access
